Creative Medical Technology Stock Today
| CELZ Stock | USD 1.90 0.03 1.55% |
PerformanceWeakest
| Odds Of DistressHigh
|
Creative Medical is trading at 1.90 as of the 9th of February 2026; that is 1.55 percent decrease since the beginning of the trading day. The stock's open price was 1.93. Creative Medical has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 11th of November 2025 and ending today, the 9th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 6th of November 2015 | Category Healthcare | Classification Health Care |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 3.49 M outstanding shares of which 361.92 K shares are currently shorted by private and institutional investors with about 2.4 trading days to cover. More on Creative Medical Technology
Moving together with Creative Stock
Moving against Creative Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Creative Stock Highlights
| President CEO, Director | Timothy Warbington | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCreative Medical utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Creative Medical's leverage profile, showing how much of Creative Medical's resources are funded through borrowing.
| ||||||||||||||||||||||||||||||||||||||||||||||
Creative Medical Technology (CELZ) is traded on NASDAQ Exchange in USA and employs 4 people. Creative Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.74 M. Creative Medical Tec conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.49 M outstanding shares of which 361.92 K shares are currently shorted by private and institutional investors with about 2.4 trading days to cover.
Creative Medical Technology currently holds about 22.86 M in cash with (5.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62.
Check Creative Medical Probability Of Bankruptcy
Ownership AllocationAlmost 92.99 percent of Creative Medical outstanding shares are held by general public with 1.0 (percent) owned by insiders and only 6.01 % by other corporate entities.
Check Creative Ownership Details
Creative Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Td Waterhouse Canada Inc | 2025-06-30 | 1.0 | |
| Org Partners Llc | 2025-06-30 | 0.0 | |
| Armistice Capital, Llc | 2025-06-30 | 0.0 | |
| Hrt Financial Llc | 2025-06-30 | 0.0 | |
| Geode Capital Management, Llc | 2025-06-30 | 20.9 K | |
| Vanguard Group Inc | 2025-06-30 | 17.6 K | |
| Northern Trust Corp | 2025-06-30 | 11.7 K | |
| Citadel Advisors Llc | 2025-06-30 | 11.1 K | |
| Hanson Mcclain Inc | 2025-06-30 | 4 K | |
| Ameritas Advisory Services, Llc | 2025-06-30 | 2.3 K | |
| Advisor Group Holdings, Inc. | 2025-06-30 | 1.1 K |
Creative Medical Historical Income Statement
Creative Stock Against Markets
Creative Medical Corporate Executives
Elected by the shareholders, the Creative Medical's board of directors comprises two types of representatives: Creative Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Medical's management team and ensure that shareholders' interests are well served. Creative Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Donald MBA | CFO VP | Profile |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.